Codex DNA, Inc. (DNAY)

NASDAQ: DNAY · IEX Real-Time Price · USD
4.17
-0.26 (-5.87%)
At close: May 20, 2022 4:00 PM
4.19
0.02 (0.48%)
After-hours:May 20, 2022 5:28 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Revenue
11.046.584.81
Revenue Growth (YoY)
67.93%36.86%-
Cost of Revenue
6.742.952.68
Gross Profit
4.33.632.13
Selling, General & Admin
25.1311.065.79
Research & Development
14.558.933.32
Other Operating Expenses
0.060.070
Operating Expenses
39.7420.069.1
Operating Income
-35.44-16.44-6.98
Interest Expense / Income
1.370.691.49
Other Expense / Income
2.140.88-0.16
Pretax Income
-38.94-18.01-8.3
Income Tax
0.010.010
Net Income
-38.96-18.01-8.3
Net Income Common
-38.96-18.01-8.3
Shares Outstanding (Basic)
18515
Shares Outstanding (Diluted)
18515
Shares Change
264.34%-66.66%-
EPS (Basic)
-2.14-3.60-0.55
EPS (Diluted)
-2.14-3.60-0.55
Free Cash Flow Per Share
-2.12-3.12-0.43
Gross Margin
38.93%55.12%44.29%
Operating Margin
-320.89%-249.92%-145.18%
Profit Margin
-352.78%-273.87%-172.78%
Free Cash Flow Margin
-349.11%-237.00%-134.63%
Effective Tax Rate
-0.04%-0.03%0.00%
EBITDA
-36-15.86-5.96
EBITDA Margin
-326.01%-241.15%-123.93%
EBIT
-37.58-17.32-6.81
EBIT Margin
-340.26%-263.31%-141.77%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).